On November 18, the World Health Organization and York University organized a virtual event to formally recognizing Global Strategy Lab as a WHO Collaborating Centre on Global Governance of Antimicrobial Resistance (AMR). This follows the original designation by the WHO in November 2019.
The authors suggest that a combination of non-binding and binding governance mechanisms supported by leading AMR use countries and important AMR stakeholders, and informed by One Health principles, may be best suited to tackle AMR governance challenges.
In the article, the authors show that progress reports suggest the implementation of AMR activities is vastly below what was promised 5 years ago. Since this commitment-compliance gap is far from unique to AMR, Weldon and Hoffman looked into lessons from IR theory to see what could be applicable to AMR.
The study surveyed Canadian health care professionals to identify AMR policies between 2008-2018. Combined with a wider policy scan the authors suggest that Canadian AMR efforts are disjointed and inadequate, given the urgency of the public health threat.
The framework identifies challenges in AMR research, areas for enhanced coordination and cooperation with decision-makers, and best practices in the design of impact evaluations for AMR policies.
The central theme revolved around two questions looking at a One Health perspective: What lessons learned from COVID-19 can be applied to AMR? And what can the emerging responses to COVID-19 learn from the social science experience in AMR to tackle the current and future pandemics?
The special issue contains three articles. An introduction to the challenges of AMR, a comparison to international agreements on climate change, and an exploration of international law as a tool for a binding agreement.